Cardinal Health Rallies As Strong Start To 2026 Fuels Higher Earnings Guidance
1. CAH beat Q1 earnings estimates with $2.55 per share, above $2.18 consensus. 2. Sales surged 22% year-over-year, reaching $64.01 billion, exceeding expectations. 3. The outlook for fiscal 2026 adjusted EPS raised to $9.65-$9.85, above $9.43. 4. Initiated a $375 million accelerated share repurchase program to enhance shareholder value. 5. Strong performance expected from Pharmaceutical and Specialty Solutions segment growth.